Freeport-McMoRan, Inc. (FCX) is currently trading at $65.00. Based on 22 Wall Street analysts, the average target price is $71.11, implying a 9.4% upside. The consensus recommendation is BUY.

FCX

Freeport-McMoRan, Inc.

MaterialsOpinion: buy

Opinion Criteria: Based on the consensus of Wall Street analysts. Strong Buy (1.0-1.5), Buy (1.5-2.5), Hold (2.5-3.5), Sell (3.5-4.5), Strong Sell (4.5-5.0).

Price (USD)

$65.00

Consensus target price range

Low–high band from analyst PT changes in the last 3 months; median & sample mean vs current price

LowHigh
$58.50$80.00
Current $65.00
Median: $76.00Mean: $73.13Current: $65.00

Recent price target updates (latest 80)

  • BarclaysJul 16, 2026

    PT action: Raises

    $77.00 → $80.00

  • Goldman SachsJul 9, 2026

    PT action: Lowers

    $75.00 → $74.00

  • JP MorganJul 9, 2026

    PT action: Raises

    $73.00 → $77.00

  • B of A SecuritiesJul 9, 2026

    PT action: Raises

    $74.00 → $80.00

  • Morgan StanleyJul 8, 2026

    PT action: Raises

    $66.00 → $70.00

  • UBSJun 30, 2026

    PT action: Raises

    $75.00 → $77.00

  • ScotiabankJun 15, 2026

    PT action: Raises

    $67.00 → $77.00

  • BernsteinJun 10, 2026

    PT action: Raises

    $53.50 → $58.50

  • BarclaysMay 22, 2026

    PT action: Announces

    $0.00 → $77.00

  • UBSMay 21, 2026

    PT action: Raises

    $74.00 → $75.00

  • CitigroupMay 4, 2026

    PT action: Lowers

    $67.00 → $66.00

  • Morgan StanleyApr 24, 2026

    PT action: Lowers

    $70.00 → $66.00

  • Wells FargoApr 15, 2026

    PT action: Raises

    $64.00 → $77.00

  • ScotiabankApr 14, 2026

    PT action: Lowers

    $72.00 → $71.00

  • JP MorganApr 9, 2026

    PT action: Raises

    $68.00 → $76.00

  • Goldman SachsApr 2, 2026

    PT action: Announces

    $0.00 → $70.00

  • UBSMar 27, 2026

    PT action: Lowers

    $70.00 → $66.00

  • ScotiabankFeb 20, 2026

    PT action: Raises

    $70.00 → $72.00

  • Freedom BrokerFeb 20, 2026

    PT action: Raises

    $47.00 → $76.00

  • Argus ResearchFeb 13, 2026

    PT action:

    $0.00 → $0.00

Band uses only the revised target (Current column) from firm actions dated within the last 3 months—not the Prior price.

Avg Target

$71.11

Based on 22 analysts

Analyst Recommendations

Buy (19)Hold (3)Sell (1)

Upside

+9.40%

Market Cap

$0.00B

Financial & Investment Metrics

P/E Ratio (TTM)34.39
Forward P/E16.06
P/B Ratio4.79
Dividend Yield0.96%
Return on Equity (ROE)15.63%
Operating Margin31.07%
Debt to Equity33.01
Beta (Volatility)1.36
52 Week Range$35.15 - $72.28
LowCurrent: $65.00High

Latest News

Daily editorial mentioning FCX

Price target moves

Healthcare and Energy Dominate July 10 Price Target Revisions

As of the morning of July 10, 2026, the desks have been busy processing a wave of target adjustments across the S&P 500. While the volume of revisions remains elevated, sector-specific sentiment appears to be pulling in competing directions, particularly within the energy and healthcare spaces.

* RBC Capital was particularly active, lifting targets across UNH, ELV, and CVS. * Energy names like DVN and AR faced downward revisions from Truist Securities. * Goldman Sachs signaled a significant adjustment for NOW, lowering the target to 145.

Notable adjustments

The movement in the healthcare sector was sharp. RBC Capital pushed UnitedHealth (UNH) from 400 to 463, while Elevance Health (ELV) saw a move from 358 to 439. CVS Health (CVS) also saw a modest lift to 113 from 107. These adjustments arrive despite a broader caution elsewhere; for instance, Piper Sandler’s subtle trim to Regeneron (REGN), moving it from 855 to 854, suggests some analysts are finding limited room for further upside in high-priced biopharma.

In the energy patch, the outlook has taken a more defensive turn. Citigroup dialed back EOG Resources (EOG) to 141 from 147, and Truist Securities lowered its expectations for both Devon Energy (DVN) and Antero Resources (AR). DVN dropped from 66 to 61, while AR shifted from 56 to 52. These downward revisions contrast with the optimism seen in other corners of the market, such as UBS pushing TSLA up to 442 from 364.

Broader watchlist context

Financials were a mixed bag of activity. Wells Fargo opted to boost the targets for MetLife (MET) and Chubb (CB), moving them to 101 and 358 respectively, while simultaneously trimming Aon (AON) to 406. Perhaps most telling was the shift in sentiment toward Intercontinental Exchange (ICE), which Barclays moved down to 180 from 201.

The materials sector also saw some cooling. Goldman Sachs lowered Freeport-McMoRan (FCX) to 74 from 75, and RBC Capital reduced its target for Newmont (NEM) to 135 from 140. For a complete view of how these shifts compare to historical trends, see the full moves database. The disparity between these downward adjustments and the more aggressive moves in industrials—where GE was lifted to 430 by Susquehanna—highlights the fragmented nature of current analyst sentiment.

Read article

Insider Sentiment Index (Last 6 Months)

Counts and listings exclude stock awards, gifts, and option exercises—open-market purchases and sales only.

Buy vs Sell (Count)

Insider Buys: 0Insider Sells: 9

Whale Trades (C-Level Large Buys)

No major insider buying detected recently.

Recent Insider Transactions

DateNamePositionTransactionShares
2/20/2026HIGGINS STEPHEN TOfficerSale at price 63.00 per share.29,654
2/18/2026MIKES ELLIE L.OfficerSale at price 62.03 per share.11,000
2/13/2026ROBERTSON MAREE EChief Financial OfficerSale at price 61.55 per share.48,500
2/11/2026CURRAULT DOUGLAS NICHOLAS IIGeneral CounselSale at price 64.52 per share.75,000
2/11/2026ADKERSON RICHARD CChairman of the BoardSale at price 62.80 - 65.21 per share.400,991
12/11/2025HIGGINS STEPHEN TOfficerSale at price 47.99 per share.28,423
12/11/2025MIKES ELLIE L.OfficerSale at price 47.66 per share.9,572
6/2/2025MIKES ELLIE L.OfficerSale at price 40.02 per share.8,584
11/11/2024ROBERTSON MAREE EChief Financial OfficerSale at price 44.91 per share.13,000

Frequently Asked Questions

Q. What is the current target price and upside for FCX?

A. The current target price for Freeport-McMoRan, Inc. is $71.11, which implies a 9.4% upside from the current price of $65.00. This is based on the consensus of 22 Wall Street analysts.

Q. What is the current analyst recommendation for FCX?

A. Currently, there are 6 Strong Buy, 13 Buy, 3 Hold, 1 Sell, and 0 Strong Sell ratings. The overall consensus is BUY.

Q. Are insiders buying FCX stock recently?

A. Over the past 6 months, there have been 0 insider buys and 9 insider sells. Insider selling is more prominent recently.

Other Promising Stocks in Materials

Data provided by Yahoo Finance. This information is for informational purposes only and does not constitute investment advice. We bear no legal responsibility for any investment decisions made based on this data.

Read full disclaimer